Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32396659)

  • 1. Histological clues to the diagnosis of metastasis to the breast from extramammary malignancies.
    Lee AHS; Hodi Z; Soomro I; Sovani V; Abbas A; Rakha E; Ellis IO
    Histopathology; 2020 Aug; 77(2):303-313. PubMed ID: 32396659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histological diagnosis of metastases to the breast from extramammary malignancies.
    Lee AH
    J Clin Pathol; 2007 Dec; 60(12):1333-41. PubMed ID: 18042689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
    Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
    Spieler P; Gloor F
    Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endobronchial Metastasis from Extrapulmonary Neoplasms: Analysis of Clinicopathologic Features and Cytological Evaluation by Bronchial Brushing.
    Ikemura K; Lin DM; Martyn CP; Park JW; Seder CW; Gattuso P
    Lung; 2017 Oct; 195(5):595-599. PubMed ID: 28555346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report.
    Maeshima Y; Osako T; Morizono H; Yunokawa M; Miyagi Y; Kikuchi M; Ueno T; Ohno S; Akiyama F
    J Med Case Rep; 2021 Feb; 15(1):78. PubMed ID: 33593410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
    Vidarsdottir H; Tran L; Nodin B; Jirström K; Planck M; Jönsson P; Mattsson JSM; Botling J; Micke P; Brunnström H
    Hum Pathol; 2019 Feb; 84():221-230. PubMed ID: 30389437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
    Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
    Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
    Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
    Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features.
    Sharma SG; Gokden M; McKenney JK; Phan DC; Cox RM; Kelly T; Gokden N
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):494-8. PubMed ID: 21102195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metastases to the breast from primary extramammary tumors--real diagnostic dilemma].
    Kinkor Z; Skálová A
    Ceska Gynekol; 2010 Dec; 75(6):560-3. PubMed ID: 27534016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating breast carcinoma with signet ring features from gastrointestinal signet ring carcinoma: assessment of immunohistochemical markers.
    Hui Y; Wang Y; Nam G; Fanion J; Sturtevant A; Lombardo KA; Resnick MB
    Hum Pathol; 2018 Jul; 77():11-19. PubMed ID: 29317235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall.
    Recine MA; Deavers MT; Middleton LP; Silva EG; Malpica A
    Am J Surg Pathol; 2004 Dec; 28(12):1646-51. PubMed ID: 15577686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis to the thyroid gland: a single-institution 16-year experience.
    Ghossein CA; Khimraj A; Dogan S; Xu B
    Histopathology; 2021 Mar; 78(4):508-519. PubMed ID: 32897542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of extramammary malignancy metastatic to the breast by fine needle biopsy.
    Wood B; Sterrett G; Frost F; Swarbrick N
    Pathology; 2008 Jun; 40(4):345-51. PubMed ID: 18446623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-epithelial malignancies and metastatic tumours of the breast.
    O'Donnell ME; McCavert M; Carson J; Mullan FJ; Whiteside MW; Garstin WI
    Ulster Med J; 2009 May; 78(2):105-12. PubMed ID: 19568446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difficulty in differential diagnosis for renal cancer with microscopic papillary architecture: overlapped pathological features among papillary renal cell carcinoma (RCC), mutinous tubular and spindle cell carcinoma, and unclassified RCC. Lessons from a Japanese multicenter study.
    Ito K; Mikami S; Kuroda N; Nagashima Y; Tatsugami K; Masumori N; Kondo T; Takagi T; Nakanishi S; Eto M; Kamba T; Tomita Y; Matsuyama H; Tsushima T; Nakazawa H; Oya M; Kimura G; Shinohara N; Asano T
    Jpn J Clin Oncol; 2020 Oct; 50(11):1313-1320. PubMed ID: 33089867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
    Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
    Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic characteristics of thyroid-like follicular carcinoma of the kidney: an analysis of five cases and review of literature].
    Chen X; Dou FX; Cheng XB; Guo AT; Shi HY
    Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):687-691. PubMed ID: 27760609
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.
    Nonaka D; Chiriboga L; Soslow RA
    Am J Surg Pathol; 2008 Oct; 32(10):1566-71. PubMed ID: 18724243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.